Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 301

1.

Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations.

Heuvelings CC, de Vries SG, Grobusch MP.

Int J Infect Dis. 2017 Jan 3. pii: S1201-9712(16)31670-8. doi: 10.1016/j.ijid.2016.12.025. [Epub ahead of print] Review. No abstract available.

2.

HIV infection rather than concurrent opportunistic infections drives most systemic procoagulant, vascular and damage responses - a prospective cohort study in central Africa.

Janssen S, Huson MA, Osbak KK, Rossatanga EG, Alabi A, Lutter R, Grobusch MP, van der Poll T.

Antivir Ther. 2017 Jan 5. doi: 10.3851/IMP3100. [Epub ahead of print]

PMID:
28054932
3.

Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine.

Grobusch MP, Goorhuis A.

Lancet. 2016 Dec 22. pii: S0140-6736(16)32619-8. doi: 10.1016/S0140-6736(16)32619-8. [Epub ahead of print] No abstract available.

PMID:
28017405
4.

Yellow fever vaccination - Once in a lifetime?

Grobusch MP, van Aalst M, Goorhuis A.

Travel Med Infect Dis. 2016 Dec 21. pii: S1477-8939(16)30210-1. doi: 10.1016/j.tmaid.2016.12.003. [Epub ahead of print] No abstract available.

PMID:
28013052
5.

Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.

Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, Schinkel J, Grobusch MP, Goorhuis A, Warnecke JM, Lattwein E, Komorowski L, Deerberg A, Saschenbrecker S, Stöcker W, Schlumberger W.

Euro Surveill. 2016 Dec 15;21(50). pii: 30426. doi: 10.2807/1560-7917.ES.2016.21.50.30426.

6.

Assay optimization for molecular detection of Zika virus.

Corman VM, Rasche A, Baronti C, Aldabbagh S, Cadar D, Reusken CB, Pas SD, Goorhuis A, Schinkel J, Molenkamp R, Kümmerer BM, Bleicker T, Brünink S, Eschbach-Bludau M, Eis-Hübinger AM, Koopmans MP, Schmidt-Chanasit J, Grobusch MP, de Lamballerie X, Drosten C, Drexler JF.

Bull World Health Organ. 2016 Dec 1;94(12):880-892.

7.

Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.

Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1265-1271.

PMID:
27928077
8.

Travel-Associated Zika Virus Disease Acquired in the Americas Through February 2016: A GeoSentinel Analysis.

Hamer DH, Barbre KA, Chen LH, Grobusch MP, Schlagenhauf P, Goorhuis A, van Genderen PJ, Molina I, Asgeirsson H, Kozarsky PE, Caumes E, Hagmann SH, Mockenhaupt FP, Eperon G, Barnett ED, Bottieau E, Boggild AK, Gautret P, Hynes NA, Kuhn S, Lash RR, Leder K, Libman M, Malvy DJ, Perret C, Rothe C, Schwartz E, Wilder-Smith A, Cetron MS, Esposito DH; GeoSentinel Surveillance Network..

Ann Intern Med. 2016 Nov 22. doi: 10.7326/M16-1842. [Epub ahead of print]

PMID:
27893080
9.

Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings.

Alabi AS, Traoré AN, Loembe MM, Ateba-Ngoa U, Frank M, Adegnika AA, Lell B, Mahoumbou J, Köhler C, Kremsner PG, Grobusch MP; CERMEL TB CapDev Group..

Int J Infect Dis. 2016 Nov 22. pii: S1201-9712(16)31622-8. doi: 10.1016/j.ijid.2016.11.404. [Epub ahead of print]

10.

Ultrasound for patients in a high HIV/TB prevalence setting - A needs assessment and review of focused applications for sub-Saharan Africa.

Heller T, Mtemang'ombe EA, Huson MA, Heuvelings CC, Bélard S, Janssen S, Phiri S, Grobusch MP.

Int J Infect Dis. 2016 Nov 8. pii: S1201-9712(16)31216-4. doi: 10.1016/j.ijid.2016.11.001. [Epub ahead of print] Review.

11.

Predictive value of the qSOFA score in patients with suspected infection in a resource limited setting in Gabon.

Huson MA, Kalkman R, Grobusch MP, van der Poll T.

Travel Med Infect Dis. 2016 Nov 5. pii: S1477-8939(16)30164-8. doi: 10.1016/j.tmaid.2016.10.014. [Epub ahead of print] No abstract available.

PMID:
27826072
12.

Tuberculosis patients' pre-hospital delay and non-compliance with a longstanding DOT programme: a mixed methods study in urban Zambia.

Cremers AL, Gerrets R, Kapata N, Kabika A, Birnie E, Klipstein-Grobusch K, Grobusch MP.

BMC Public Health. 2016 Oct 28;16(1):1130.

13.

Therapeutic Drug Monitoring in Tuberculosis: Practical Application for Physicians.

Alffenaar JC, Tiberi S, Verbeeck RK, Heysell SK, Grobusch MP.

Clin Infect Dis. 2017 Jan 1;64(1):104-105. No abstract available.

PMID:
27789609
14.

Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.

Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N.

Acta Trop. 2016 Dec;164:329-336. doi: 10.1016/j.actatropica.2016.09.008.

PMID:
27647575
15.

Zika virus: who's next?

Goorhuis A, Grobusch MP.

Lancet Infect Dis. 2016 Nov;16(11):1204-1205. doi: 10.1016/S1473-3099(16)30316-4. No abstract available.

PMID:
27593583
16.

Phagocytosis of hemozoin by RAW 264.7 cells, but not THP-1 cells, promotes infection by Leishmania donovani with a nitric oxide-independent mechanism.

van den Bogaart E, Mens PF, Adams ER, Grobusch MP, Schallig HD.

Parasitol Int. 2016 Sep 10. pii: S1383-5769(16)30333-6. doi: 10.1016/j.parint.2016.09.003. [Epub ahead of print]

PMID:
27623326
17.

Individualizing management of extensively drug-resistant tuberculosis: diagnostics, treatment, and biomarkers.

Alffenaar JC, Akkerman OW, Anthony RM, Tiberi S, Heysell S, Grobusch MP, Cobelens FG, Van Soolingen D.

Expert Rev Anti Infect Ther. 2017 Jan;15(1):11-21.

PMID:
27762157
18.

Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study.

Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MC, van Genderen PJ, Goorhuis A, Grobusch MP, Lashof AM, Molhoek N, Schultsz C, Stobberingh EE, Verbrugh HA, de Jong MD, Melles DC, Penders J.

Lancet Infect Dis. 2017 Jan;17(1):78-85. doi: 10.1016/S1473-3099(16)30319-X.

PMID:
27751772
19.

Mapping Zika virus disease incidence in Valle del Cauca.

Rodriguez-Morales AJ, Galindo-Marquez ML, García-Loaiza CJ, Sabogal-Roman JA, Marin-Loaiza S, Ayala AF, Lagos-Grisales GJ, Lozada-Riascos CO, Parra-Valencia E, Rojas-Palacios JH, López E, López P, Grobusch MP.

Infection. 2016 Oct 14. [Epub ahead of print]

PMID:
27743307
20.

Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia.

Chanda-Kapata P, Kapata N, Masiye F, Maboshe M, Klinkenberg E, Cobelens F, Grobusch MP.

PLoS One. 2016 Oct 6;11(10):e0163975. doi: 10.1371/journal.pone.0163975.

Items per page

Supplemental Content

Loading ...
Support Center